Clinical Trial

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2024 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study investigate what information individuals with SCD or MCI and their co-participant would like to receive during pre-diagnostic counseling and diagnostic disclosure, and how this information should be conveyed.
Trial Details
NCT Number NCT06621758
Lead Sponsor Danish Dementia Research Centre
Collaborators: Toulouse University Hospital, Department of Geriatric & Internal Medicine, France, Universitair Ziekenhuis Brussel, Department of Neurology, Belgium, University Medical Centre Ljubljana, Department of Neurology, Slovenia
Conditions Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
Enrollment 120 participants
Start Date 2024-10-15
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-01